NPM1 and acute myeloid leukemia: Characteristic mutations in NPM1 occur in a third of adult AML patients and they are considered to be a positive prognostic factor, at least in the absence of karyotype aberration and of other recurrent gene mutations, according to European Leukemia Net guidelines.